These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21827580)

  • 1. Exploiting the antioxidant potential of a common vitamin: could vitamin C prevent postmenopausal osteoporosis?
    Talaulikar VS; Chambers T; Manyonda I
    J Obstet Gynaecol Res; 2012 Jan; 38(1):253-7. PubMed ID: 21827580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women.
    Pasco JA; Henry MJ; Wilkinson LK; Nicholson GC; Schneider HG; Kotowicz MA
    J Womens Health (Larchmt); 2006 Apr; 15(3):295-300. PubMed ID: 16620188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women.
    Hartman TJ; Baer DJ; Graham LB; Stone WL; Gunter EW; Parker CE; Albert PS; Dorgan JF; Clevidence BA; Campbell WS; Tomer KB; Judd JT; Taylor PR
    Eur J Clin Nutr; 2005 Feb; 59(2):161-8. PubMed ID: 15367922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C as an antioxidant supplement in women's health: a myth in need of urgent burial.
    Talaulikar VS; Manyonda IT
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):10-3. PubMed ID: 21507551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study.
    Sanders KM; Kotowicz MA; Nicholson GC
    Transl Res; 2007 Oct; 150(4):215. PubMed ID: 17900508
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in markers of inflammation, antioxidant capacity and oxidative stress in smokers following consumption of milk, and milk supplemented with fruit and vegetable extracts and vitamin C.
    Hunter DC; Brown R; Green T; Thomson C; Skeaff M; Williams S; Todd JM; Lister CE; McGhie T; Zhang J; Martin H; Rippon P; Stanley R; Skinner MA
    Int J Food Sci Nutr; 2012 Feb; 63(1):90-102. PubMed ID: 21770863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
    Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C
    Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamins C and E: acute interactive effects on biomarkers of antioxidant defence and oxidative stress.
    Choi SW; Benzie IF; Collins AR; Hannigan BM; Strain JJ
    Mutat Res; 2004 Jul; 551(1-2):109-17. PubMed ID: 15225585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ; Im JA; Kim SH
    Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
    Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral preoperative antioxidants in pancreatic surgery: a double-blind, randomized, clinical trial.
    Braga M; Bissolati M; Rocchetti S; Beneduce A; Pecorelli N; Di Carlo V
    Nutrition; 2012 Feb; 28(2):160-4. PubMed ID: 21890323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis.
    Ozgocmen S; Kaya H; Fadillioglu E; Yilmaz Z
    Arch Med Res; 2007 Feb; 38(2):196-205. PubMed ID: 17227729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.